ScinoPharm Taiwan - Asia's API Resource



		Technical Services > ScinoPharm offers a full spectrum of capabilities starting from the earliest stage of synthesizing potential NCE's through large-scale commercial operation. Manufacturing > ScinoPharm can assure on-time development of non-infringing patent processes and timely delivery of high quality, price competitive API's to our downstream customers. Biotechnology > ScinoPharm is actively involved in research related to new drug discovery and traditional Chinese medicine genome project.

The ScinoPharm Advantage
ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry.

Combining cost-effective resources and productivity of Asia along with unmatched regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector.

News, Press Coverage, and Press Releases

October 15, 2007 | ScinoPharm Reports Record-high Performance

February 26, 2007 | ScinoPharm’s 2006 Revenue and Net Income at Record High

January 18, 2007 | ScinoPharm Launches More Cancer Treatment APIs in the US

More News, Coverage, and Press Releases >



		Video - Introduction to ScinoPharm Video - High Potency Capabilities Video - Peptide Technology More Highlights >